Advertisement

Topics

The Critical Path Institute Company Profile

02:51 EDT 26th September 2018 | BioPortfolio

The Critical Path Institute (C-Path) is an independent, publicly funded, non-profit organization dedicated to the critical path initiative. C-Path fosters research and educational programs intended to enable the pharmaceutical industry to safely accelerate the development of new medications. C-Path has three founding partners:The U.S. Food and Drug Administration (FDA)
The University of Arizona (UA)
SRI International (SRI)
Each partner contributes unique strengths to C-Path. UA provides the academic home and infrastructure for C-Path’s educational and research programs and an environment of innovation and inquiry. The participating FDA scientists provide the first-hand knowledge of the regulatory process, a wealth of experience in the evaluation of new pharmaceutical agents and awareness of opportunities for improvement. SRI brings practical experience in pharmaceutical development, scientific expertise, and a track record of commercializing new medical products

Location

4280 N. Campbell Avenue, Suite 214
Tucson
Arizona
85718
United States of America

Contact

Phone: 1-520-547-3440
Fax: 1-520-547-3456
Email: Info@C-Path.org


News Articles [1001 Associated News Articles listed on BioPortfolio]

Doris Duke Charitable Foundation awards grant to Critical Path Institute

(Critical Path Institute (C-Path)) The Doris Duke Charitable Foundation today announced a grant to the Critical Path Institute (C-Path) to lay the groundwork for forming a collaboration of multiple st...

Helmsley Charitable Trust awards Critical Path Institute a grant to focus on Crohn's disease

(Critical Path Institute (C-Path)) The Leona M. and Harry B. Helmsley Charitable Trust has awarded Critical Path Institute (C-Path) a grant to support a Crohn's disease biomarker pre-consortium. The p...

First-ever qualified Parkinson's biomarker is vital step toward improved clinical trials

(Critical Path Institute (C-Path)) The Critical Path Institute's (C-Path) Critical Path for Parkinson's Consortium (CPP), in partnership with Parkinson's UK, announces that the European Medicines Agen...

C-Path receives COA qualification from FDA for the non-small cell lung cancer SAQ

(Critical Path Institute (C-Path)) Critical Path Institute's (C-Path) Patient-Reported Outcome (PRO) Consortium announces its second clinical outcome assessment (COA) qualification from the US Food an...

EMA issues positive opinion on biomarker for Parkinson’s trials

Critical Path Institute’s (C-Path) Critical Path for Parkinson’s Consortium (CPP), along with Parkinson’s UK, has announced that the European Medicines...Read More... The post EMA issues positiv...

C-Path and CHDI launch consortium to accelerate development of Huntington's therapies

(Critical Path Institute (C-Path)) C-Path and CHDI announce the launch of the Huntington's Disease Regulatory Science Consortium (HD-RSC) to advance innovation in regulatory science methods, drug deve...

Counter Talk: Repave shoppers’ path to purchase

Path to Purchase Institute’s managing director, Joan Driggs,

TSRI researchers show path to developing treatments for Charcot-Marie-Tooth disease

Scientists at The Scripps Research Institute have now shown a path to developing treatments for disease subtype CMT2D.

PubMed Articles [1483 Associated PubMed Articles listed on BioPortfolio]

Critical path of women in situations of intimate partner violence.

To know and analyze the critical path followed by women subjected to intimate partner violence until reaching a Reference Center of a Brazilian city, from the perspective of these women.

Increasing Access to Palliative Care Services in the Intensive Care Unit.

The Institute of Medicine's report, Dying in America, highlights the critical need for the widespread implementation of palliative care to improve end-of-life care. Approximately 20% of all deaths in ...

Evidence for a Bis(Elongated σ)-Dihydrideborate Coordinated to Osmium.

The formation and Atoms in Molecules (AIM) analysis of osmium(IV) and osmium(II) complexes containing dihydrideborate groups and primary aminoborane ligands are reported. Complex OsH(PPr)(1) loses a h...

The FDA/critical path initiative/Duke-Margolis center for health policy public workshop on analytical validation of assays for biomarker qualification: an update on the white paper.

Congestion patterns of electric vehicles with limited battery capacity.

The path choice behavior of battery electric vehicle (BEV) drivers is influenced by the lack of public charging stations, limited battery capacity, range anxiety and long battery charging time. This p...

Clinical Trials [1857 Associated Clinical Trials listed on BioPortfolio]

Electronic Decision Support for Intervention in Poorly Controlled Type 2 Diabetes

To determine the impact of an electronic decision support tool on physician decision making and patient outcomes for the treatment of poorly controlled diabetes mellitus. Primary endpoint ...

Improvements in Cognitive Skills of Older Adults Using Dynamic Visual Attention Training

The proposed SBIR Phase I study tests the feasibility of PATH neurotraining for improving cognitive skills in older adults and, potentially, forestalling or protecting against cognitive de...

Clinical Evaluation of Therapy™ Cool Path™ Duo Cardiac Ablation System for the Treatment of Typical Atrial Flutter (AFL)

The purpose of this study is to demonstrate that ablation with the Therapy™ Cool Path™ Duo cardiac ablation system can eliminate typical atrial flutter and that its use does not result...

A Patient-Centered PaTH to Addressing Diabetes

The overarching goal of this proposal is to understand the comparative effectiveness of obesity counseling as covered by CMS in improving weight loss for adults either with or at high risk...

Clinical Evaluation of Therapy Cool Path Duo Cardiac Ablation System for the Treatment of Ischemic Ventricular Tachycardia (VT)

To demonstrate that ablation with the Therapy Cool Path Duo cardiac ablation system can eliminate ischemic VT and that its use does not result in an unacceptable risk of serious adverse ev...

Companies [2077 Associated Companies listed on BioPortfolio]

Critical Path Institute (C-Path)

The Critical Path Institute (C-Path) is an independent, non-profit organization established in 2005 with public and private philanthropic support from the Arizona community, Scien...

The Critical Path Institute

The Critical Path Institute (C-Path) is an independent, publicly funded, non-profit organization dedicated to the critical path initiative. C-Path fosters research and educational programs intended t...

Critical Path Institute

An independent, non-profit organization established in 2005 with public and private philanthropic support from the Southern Arizona community, Science Foundation Arizona (SFAz), a...

PATH and GAVI Alliance

PATH is an international nonprofit organization that creates sustainable, culturally relevant solutions, enabling communities worldwide to break longstanding cycles of poor health...

The Critical Path to TB Drug Regimens

CPTR is a cross-sector initiative that aims to speed the introduction of shorter, safer, more effective new TB drug regimens. This effort brings together leading international pha...

More Information about "The Critical Path Institute" on BioPortfolio

We have published hundreds of The Critical Path Institute news stories on BioPortfolio along with dozens of The Critical Path Institute Clinical Trials and PubMed Articles about The Critical Path Institute for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Critical Path Institute Companies in our database. You can also find out about relevant The Critical Path Institute Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record